IONS Dividend History & Analysis | N/A Yield
IONS has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Dividends Cash Amount per Share Yearly
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| BTX | 1,436 M | 13.0% | 6.89% |
| ABBV | 395,859 M | 3.64% | 9.60% |
| GILD | 152,880 M | 2.64% | 6.48% |
| AMGN | 170,903 M | 2.93% | 4.82% |
| HLN | 41,457 M | 1.79% | 2.46% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BTX | 1,436 M | 203% | 90.0% |
| GRFS | 7,645 M | 127% | 56.8% |
| HLN | 41,457 M | 51.0% | 100% |
| AMGN | 170,903 M | 8.90% | 100% |
| ABBV | 395,859 M | 7.06% | 100% |
Similar Stocks with Attractive Dividends - Compare IONS Dividends with its Peer-Group
3.64% Yield
2.93% Yield
2.64% Yield
1.79% Yield
IONS Dividend History: Last 7 Payments (USD) as of December 2025
| Ex-Dividend Date | Record Date | Payment Date | Period | Dividend per Share | Dividend Growth Rate QoQ | Payout Yield |
|---|---|---|---|---|---|---|
| 2000-02-17 | 0.11 | 0% | N/A | |||
| 1999-12-21 | 0.11 | 0% | N/A | |||
| 1999-08-20 | 0.11 | 0% | N/A | |||
| 1999-07-21 | 0.11 | 0% | N/A | |||
| 1999-06-21 | 0.11 | 0% | N/A | |||
| 1999-03-22 | 0.11 | 0% | N/A | |||
| 1999-02-17 | 0.11 | 0% | N/A |
IONS Dividend FAQ
Ionis Pharmaceuticals (NASDAQ:IONS) is a commercial-stage biotech focused on RNA-targeted therapeutics, with FDA-approved products spanning rare metabolic, neuromuscular and neurodegenerative diseases, including TRYNGOLZA (familial chylomicronemia syndrome), WAINUA and TEGSEDI (hereditary transthyretin-mediated amyloidosis), SPINRAZA (spinal muscular atrophy), QALSODY (ALS) and WAYLIVRA (familial partial lipodystrophy). The firm also maintains an extensive pipeline of RNA-based candidates in Phase 2/3, such as Olezarsen for hypertriglyceridemia, Donidalorsen for hereditary angioedema, and Pelacarsen targeting lipoprotein(a) reduction.
What is the Dividend Yield of IONS?
As of December 2025, IONS`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - USD by the current share price of 79.76.Does IONS pay a dividend?
As of December 2025 IONS does not pay a dividend.How often does IONS pay dividends?
Over the last 12 months, IONS has issued 0 dividend payments. The last dividend payment was made on 2000-02-17.IONS dividend forecast
Based on historical data, the forecasted dividends per share for IONS for the next 4 payments are between 0.11 (+0.0%) and 0.11 (+0.0%).This suggests the dividend will remain relatively stable.
Will IONS pay dividends in 2025?
The latest dividend paid per share was 0.11 USD with an Ex-Dividend Date of 2000-02-17. The next Ex-Dividend date for Ionis Pharmaceuticals (IONS) is currently unknown.What is the next Ex-Dividend Date for IONS?
The next Ex-Dividend date for Ionis Pharmaceuticals (IONS) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of IONS?
IONS's average dividend growth rate over the past 5 years is 0.00% per year.
What is the Yield on Cost of IONS?
IONS's 5-Year Yield on Cost is -%. If you bought IONS's shares at 51.19 USD five years ago, your current annual dividend income (- USD per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of IONS?
IONS Payout Consistency is 0.8%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Very unstable: Ionis Pharmaceuticals has a poor track record of dividend payments over its lifetime.
Does IONS have a good Dividend Yield?
IONS`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of IONS?
The Dividend Payout Ratio of IONS is unknown.What is the Dividend Rating of IONS?
IONS`s Overall Dividend Rating is 0.21%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-11-18 12:10